Clinical trial

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating…

NCT00002701 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status

Key facts

NCT number NCT00002701
Title Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
Official title INDUCTION WITH ALL-TRANS RETINOIC ACID IN COMBINATION WITH IDARUBICIN AND INTENSIVE CONSOLIDATION FOLLOWED BY BONE MARROW TRANSPLANTATION OR A RANDOMIZED MAINTENANCE TREATMENT DEPENDING UPON THE AMOUNT OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators Gruppo Italiano Malattie EMatologiche dell'Adulto
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Leukemia
Intervention type Drug, Procedure, Radiation
Interventions busulfan, cyclophosphamide, cytarabine, etoposide, idarubicin, mercaptopurine, methotrexate, mitoxantrone hydrochloride, thioguanine, tretinoin and 3 more
Enrollment 750
Start date Oct 1, 1995
First posted Apr 11, 2003
Last update posted Sep 20, 2013
Countries Austria, Belgium, Croatia, Czechia, France, Germany, Italy, Netherlands, Turkey (Türkiye)

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies